These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1251680)
21. Red cell electrophoretic mobility test for early diagnosis of multiple sclerosis. Tamblyn CH; Swank RL; Seaman GV; Zukoski CF Neurol Res; 1980; 2(1):69-83. PubMed ID: 6114451 [TBL] [Abstract][Full Text] [Related]
22. [Demonstration of a factor in cerebrospinal fluid with inhibitory activity for electrophoretic cell mobility in multiple sclerosis (author's transl)]. Jenssen HL; Meyer-Rienecker HJ; Werner H J Neurol; 1976 Nov; 214(1):45-59. PubMed ID: 62827 [TBL] [Abstract][Full Text] [Related]
23. [Use of the macrophage-electrophoretic-mobility test in the diagnosis of tumours of the central nervous system (author's transl)]. Meyer-Rienecker H; Jenssen HL; Köhler H; Günther JK Dtsch Med Wochenschr; 1975 Mar; 100(11):538-43. PubMed ID: 163724 [TBL] [Abstract][Full Text] [Related]
24. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer. Arvilommi H; Dale MM; Desai HN; Mongar JL; Richardson M Br J Cancer; 1977 Nov; 36(5):545-9. PubMed ID: 588418 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the red blood cell cytopherometric test for the diagnosis of multiple sclerosis. Stoof JC; Vrijmoed-de Vries MC; Koetsier JC; Langevoort HL Acta Neurol Scand; 1977 Aug; 56(2):170-6. PubMed ID: 899719 [TBL] [Abstract][Full Text] [Related]
26. The analysis of the red cell unsaturated fatty acid test for multiple sclerosis using laser cytopherometry. Jones R; Preece AW; Luckman NP; Forrester JA Phys Med Biol; 1983 Oct; 28(10):1145-51. PubMed ID: 6647546 [TBL] [Abstract][Full Text] [Related]
27. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer. Harlos JP; Weiss L Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907 [TBL] [Abstract][Full Text] [Related]
28. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis. Crozier EH; Hollinger ME; Woodend BE; Robertson JH J Clin Pathol; 1976 Jul; 29(7):608-9. PubMed ID: 988059 [TBL] [Abstract][Full Text] [Related]
29. The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum. Glaves D; Harlos JP; Weiss L Int J Cancer; 1977 Apr; 19(4):474-81. PubMed ID: 66210 [TBL] [Abstract][Full Text] [Related]
30. A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests. Shenton BK; Jenssen HL; Werner H; Field EJ J Immunol Methods; 1977; 14(2):123-39. PubMed ID: 138709 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the erythrocyte-UFA (E-UFA) mobility test for the diagnosis of multiple sclerosis. Cuypers J; Reddemann H J Neurol Neurosurg Psychiatry; 1980 Nov; 43(11):995-8. PubMed ID: 7441283 [TBL] [Abstract][Full Text] [Related]
32. Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection. Shenton BK; Hughes D; Field EJ Br J Cancer Suppl; 1973 Aug; 1():215-8. PubMed ID: 4804280 [TBL] [Abstract][Full Text] [Related]
33. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis. Fike RM; van Oss CJ Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499 [TBL] [Abstract][Full Text] [Related]
34. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases]. Günther J Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours. Rahi AH; Otiko G; Winder AF Br J Ophthalmol; 1976 Aug; 60(8):589-93. PubMed ID: 61762 [TBL] [Abstract][Full Text] [Related]
36. The macrophage electrophoretic mobility (MEM) test for the diagnosis of hydatidiform mole and choriocarcinoma. Preliminary report. Klausch B; Straube W; Hofmann R; Büttner HH; Jenssen HL; Köhler H; Günther J Ann Chir Gynaecol; 1977; 66(4):209-13. PubMed ID: 71873 [TBL] [Abstract][Full Text] [Related]
37. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas. Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087 [TBL] [Abstract][Full Text] [Related]
38. Sensitization of cerebrospinal fluid and peripheral blood lymphocytes to myelin basic protein in multiple sclerosis. Członkowska A; Półtorak M; Cendrowski W; Korlak J Acta Neurol Scand; 1982 Jul; 66(1):121-9. PubMed ID: 6180592 [TBL] [Abstract][Full Text] [Related]
39. Further observations with the erythrocyte-unsaturated fatty acid test. A contribution to the genetics of multiple sclerosis. Joyce G; Field EJ Eur Neurol; 1980; 19(4):266-72. PubMed ID: 7398689 [TBL] [Abstract][Full Text] [Related]
40. Lymphocyte sensitization to basic protein of brain in multiple sclerosis and other neurological diseases. Caspary EA; Field EJ J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):701-3. PubMed ID: 4135820 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]